Elena A. Degtyareva

Elena A. Degtyareva

Auto-generated profile, based on publicly available information

Elena A. Degtyareva

Podolsk Children's Hospital; Peoples' Friendship University of Russia

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2022 in Voprosy praktičeskoj pediatrii
Verified
Journal Article
Closed access
EDE.A. Degtyareva
E.A. Degtyareva
M6Moscow Children'S Clinical Hospital For Infectious Diseases No 6
Moscow Children'S Clinical Hospital For Infectious Diseases No 6
AGA.V. Gorelov
A.V. Gorelov
HSH.Yu. Simonovskaya
H.Yu. Simonovskaya
EIE.P. Isaeva
E.P. Isaeva
PHPodolsk Podolsk Children'S City Hospital
Podolsk Podolsk Children'S City Hospital
Approximately 5–15% of children develop post-COVID-19 syndrome after SARS-CoV-2 infection, which manifests itself with various pathological symptoms for more than 12 weeks. Cardiovascular symptoms range from serious myocardial inflammation, manifestations of essential hypertension to signs of autonomic dysfunction with a tendency to hypersympathicotonia, which negatively affects the quality of life of children. We report a case of subacute myocarditis in a patient with long-COVID after a low-symptomatic acute disease. This case illustrates high clinical significance of timely diagnosis of long-COVID using gadolinium-enhanced magnetic resonance imaging, which was performed in our country for the first time in pediatric practice. We developed criteria for early diagnosis of autonomic dysfunction specific for children and adolescents. We also developed treatment recommendations, including behavioral therapy, drug, and non-drug treatments. Key words: long-COVID, autonomic dysfunction, hypersympathicotonia, myocarditis, behavioral therapy, non-drug treatment

24 June 2024 in CHILDREN INFECTIONS
Verified
Journal Article
Open access
PDF file
NKNataliya Kolganova
Nataliya Kolganova
DODmitry Ovsyannikov
Dmitry Ovsyannikov
AAA. E. Angel
A. E. Angel
MBM. V. Biryukova
M. V. Biryukova
SGSh. A. Gitinov
Sh. A. Gitinov
ДОД. Ю. Овсянников
Д. Ю. Овсянников
Mycoplasma pneumoniae (M. pn.), which is a well-known pathogen to cause atypical pneumonia, in 25% of cases can lead to a wide range of extra-pulmonary symptoms, reflecting damage to almost any organ or organ system (skin and mucous membranes, nervous, cardiovascular, gastrointestinal, urinary system etc.). Aspecific syndrome Mycoplasma pneumoniae-induced rash and mucositis (MIRM) has been identified recently. Among the CNS manifestations associated with M. pn., acute postinfectious cerebellar ataxia is worth mentioning. In this article we present clinical cases of a 14-year-old boy and a 6-year-old girl with extrapulmonary manifestations of M. pn. infection. This article considers etiological, pathogenetic and clinical features of mycoplasma infection in children with an emphasis on extra-respiratory manifestations.

13 December 2021 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
YNYu.Yu. Novikova
Yu.Yu. Novikova
DODmitry Ovsyannikov
Dmitry Ovsyannikov
AGA.A. Glazyrina
A.A. Glazyrina
NZN.N. Zvereva
N.N. Zvereva
SPS.S. Peters
S.S. Peters
YHYekaterinburg Sverdlovsk Oblast Regional Children’s Clinical Hospital
Yekaterinburg Sverdlovsk Oblast Regional Children’s Clinical Hospital
Coronavirus disease 2019 (COVID-19) in children in most cases is asymptomatic or mild, and its most severe late complication is multisystem inflammatory syndrome in children (MIS-C). The aim of the study is to find clinical, laboratory and instrumental characteristics, description of therapeutic tactics, including determination of the profile of patients requiring Tocilizumab prescription and the outcomes of MIS-C associated with COVID-19. Materials and methods of research: 245 children aged 3 months – 17 years old were included in the pilot prospective multicenter open-label comparative study with MIS-C associated with COVID-19, verified based on CDC criteria (2020). Results: the median age of patients was 8 [5; 10] years, boys predominated among the patients (57.1%); MIS-C manifested itself as a combination of the symptom complex of Kawasaki disease (KD, 53.1% of patients), more often of atypical form, cardiovascular (66.1%), gastrointestinal (61.2%), neurological (27.3%) symptoms and signs of detection of the urinary (29.4%) and respiratory (19.6%) systems; macrophage activation syndrome (MAS) was diagnosed in 19.5% of patients. Therapy included glucocorticosteroids (97.6%), antibiotics (95.5%), anticoagulants (93.9%), intravenous immunoglobulin (34.7%), vasoactive/vasopressor support (31.8%), Tocilizumab (15.1%), mechanical ventilation (2.4%), extracorporeal membrane oxygenation (0.4%). Patients receiving Tocilizumab, statistically significantly more often compared with patients without this therapy, were in the intensive care unit (ICU, 86.5% versus 40.9%, p<0.001), more often required vasopressor therapy (70.3% versus 25%, p<0.001), had statistically significantly higher markers of laboratory inflammatory activity. Treatment in 47.8% of cases was carried out in an ICU; one child has died. In 4.1%, according to echocardiography, coronaritis, ectasia of the coronary arteries without the formation of persistent aneurysms were detected. Conclusion: MIS-C associated with COVID-19 has clinical signs of KD, often of the incomplete form, accompanied by arterial hypotension/shock, MAS, which requires intensive therapy, and the prescription of Tocilizumab.

10 December 2024 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
APA.P. Prodeus
A.P. Prodeus
NON.D. Odinayeva
N.D. Odinayeva
SVS.V. Voronin
S.V. Voronin
IZIrina Zakharova
Irina Zakharova
MEMoscow Russian Medical Academy For Continuous Professional Education
Moscow Russian Medical Academy For Continuous Professional Education
ARA.G. Rumyantsev
A.G. Rumyantsev
A.P. Prodeus, N.D. Odinayeva, S.V. Voronin, I.N. Zakharova, I.A. Tuzankina, N.N. Volodin, K.V. Zhdanov, A.N. Pampura, D.I. Sadykova, E.I. Kondratyeva, A.A. Korsunskiy, E.A. Degtyareva, K.V. Savostyanov, S.A. Trusova, A.Yu. Lobenskaya, Ye.S. Nikonova, A.S. Lebedeva, E.V. Loshkova, V.D. Denisova, A.G. Rumyantsev. Guidelines for routing, monitoring and management tactics of immunocompromised children at risk and patients with congenital immune defects. Pediatria n.a. G.N. Speransky. 2024; 103 (6): 218-245. DOI: 10.24110/0031-403X-2024-103-6-218-245. [Reviewed by Drs. O.V. Zaytseva, N.I. Zakharova and O.V. Kalyuzhin. Approved as official Guidelines for Practitioners by the Educational and Methodological Commission of the Research and Clinical Institute of Childhood with the Moscow Oblast Healthcare Ministry (Mytishchi, Moscow Oblast, Russia), Record No. 8 dated Nov. 11, 2024]

26 March 2025 in Current Pediatric Reviews
Verified
Journal Article
Open access
PDF file
DEDegtyareva Elena
Degtyareva Elena
MMMwela Bupe Mumba
Mwela Bupe Mumba
PAProdeus Andrey
Prodeus Andrey
ODOvsyannikov Dmitry
Ovsyannikov Dmitry
KMKantemirova Marina
Kantemirova Marina
KIKorsunsky Iliya
Korsunsky Iliya
The literature review presents data from a limited number of available studies conducted over the last two decades on immunological deficiency in congenital heart defects (CHDs), which is the cause of frequent infectious complications before and after cardiac surgery. Several studies based on screenings at various levels indicate the presence of primary and secondary immunodeficiency in CHDs, in particular about 13 genetic syndromes in which CHD is combined with immunodeficiency. The available data suggests a greater severity of immunological disorders in patients with critical CHDs, cyanotic CHDs, and conotruncal defects with T-cell dysfunction and deficiency of immunoglobulins (especially the IgG class, mainly IgG4) than in patients with shunts and obstructive defects. To identify defects in the T- and B-cell components of the immune system, quantification of the DNA of T-cell receptor excision circles (TRECs) and K-deleting recombination excision circles (KRECs)-by-products of the maturation of T- and B-cell receptors- has proven helpful in the world practice of neonatal screening. It allows the evaluation of a number of functionally mature T- and B-cells. In Russia, however, its widespread use started only in 2023. Data on the use of this assay in infants with CHDs are represented by isolated case reports. In Russia, a combination of CHD and primary immunodeficiency was found in 37% of cases in the Sverdlovsk Region. We conducted our own study of 200 children with CHD; 5% of cases were syndromic forms of CHD. 48.5% of children were admitted to the cardiac surgery clinic in critical condition. A decrease in the TREC level was detected in 23.5% of cases, including all children with syndromic CHD. In the group of patients with immunological disorders, there were significantly more children with cyanotic CHD, children admitted in critical condition, and children with conotruncal defects. Infectious complications in the postoperative period (sepsis, pneumonia, tracheobronchitis, postoperative wound infection) were observed significantly more often in 47 children with reduced TREC levels compared to children with normal TREC levels (P = .00000, in 36% and 3.6%, respectively). The analysis of publications confirms the prognostic value of TREC and KREC screening for targeted preoperative preparation to reduce postoperative complications and decrease the risk of mortality in CHDs.

12 August 2019 in Pediatria. Journal named after G.N. Speransky
Verified
Journal Article
Closed access
EDE.A. Degtyareva
E.A. Degtyareva
MKM.A. Kufa
M.A. Kufa
MKM.G. Kantemirova
M.G. Kantemirova
ANA.V. Nikopolskya
A.V. Nikopolskya
EBE.M. Bragina
E.M. Bragina
ASA.N. Shuvalov
A.N. Shuvalov
Облако Mail.Ru - это ваше персональное надежное хранилище в интернете. Все нужные файлы всегда под рукой, доступны в любой точке мира с компьютера или смартфона.